Your session is about to expire
← Back to Search
UVB treatment for Vitamin D Deficiency
Study Summary
This trial will test the safety and effectiveness of the Solius Photobiological System in improving serum levels of 25-hydroxyvitamin D in vitamin D deficient/ insufficient adults of various skin types.
- Vitamin D Deficiency
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Anyone can participate regardless of gender.Your skin type falls within the range of Type I-VI.You have taken medication for allergies called H1 antihistamines in the past week.You take more than 600 International Units (IU) of vitamin D supplements every day.You have a past diagnosis of skin cancer.You have been diagnosed with a condition that makes you sensitive to light, such as protoporphyria, photodermatitis, xeroderma pigmentosum, lupus erythematosus, chronic actinic dermatitis, or UV-sensitive syndrome.You have used a tanning bed or received phototherapy treatment in the past month.You are currently pregnant.You have mild allergic reactions to sunlight, such as itchy skin, rashes, or hives.You have a history of being overly sensitive to sunlight.You are taking medications that make your skin sensitive to sunlight, such as tetracycline, doxycycline, and hydrochlorothiazide.You plan to be in areas with strong sunlight below the 33rd parallel during the study.You are currently taking steroids for a medical condition.
- Group 1: Sham comparator arm
- Group 2: UVB treatment arm
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are people still being signed up for this experiment?
"Yes, recruitment for this study is still open. According to the clinicaltrials.gov website, this trial was first posted on February 23rd, 2022 and updated as recently as October 21st of the same year."
How many subjects are enrolled in the clinical trial?
"The answer is affirmative, the clinical trial in question is presently recruiting patients. The listing on clinicaltrials.gov reveals that the first posting was on February 23rd, 2022 with the most recent update being October 21st, 2022. They are seeking 100 individuals to take part in this study at a single location."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger